Table 3

Survival dependent on receptor content and normal or high levels of serum YKL-40 and HER2

Receptor content at primary diagnosisSerum YKL-40 levelSerum HER2 levelNo.Median survival in months (95% CI)2- and 5-years actuarial survival
Positive (n = 71)NormalNormal3939 (23–54)67%, 28%
Normal5134 (25–42)65%, 22%
Normal4833 (19–47)58%, 23%
High2316 (9–24)40%, 4%
High2013 (10–17)20%, 5%
HighHigh1112 (9–15)18%, 9%
Negative (n = 29)NormalNormal1519 (10–28)33%, 27%
Normal1915 (7–24)32%, 21%
Normal2013 (5–21)25%, 20%
High96 (5–8)11%, 0%
High104 (0–9)0%
HighHigh54 (1–7)0%